Researcher
Bert Schepens
- Disciplines:Biophysics, Molecular and cell biology, Laboratory medicine, Microbiology, Systems biology, Plant biology, Medicinal and biomolecular chemistry
Affiliations
- Department of Biochemistry and microbiology (Department)
Member
From1 Oct 2019 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Feb 2001 → 30 Sep 2019
Projects
1 - 4 of 4
- Novel Respiratory Syncytial VaccineFrom1 Aug 2012 → 31 Jan 2014Funding: IOF - Industrial Research Fund
- Phosphoproteome analysis of host-RSV interactionsFrom1 Oct 2011 → 1 Oct 2012Funding: BOF - Doctoral projects
- The SH protein of human RSV: a possible proton channel that can be targeted by a vaccine.From1 Oct 2009 → 30 Sep 2015Funding: BOF - Other initiatives, FWO fellowships
- Development of a RSV vaccine based on virus like particles that display short fragments of viral surface proteinsFrom1 Jan 2009 → 30 Dec 2011Funding: FWO research grant KAN
Publications
1 - 10 of 58
- Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies(2022)
Authors: Teodora-Eugenia Oltean, Lorena Ibanez, Tatyana Divert, Tine Ysenbaert, Hannelore Van Eeckhoutte, Vera Goossens, Michael Schotsaert, Ken Bracke, Bert Schepens, Jonathan Maelfait, et al.
- An unexpected encounter : respiratory syncytial virus nonstructural protein 1 interacts with mediator subunit MED25(2022)
Authors: Tessa Van Royen, Koen Sedeyn, Georgios Moschonas, Wendy Toussaint, M Vuylsteke, Delphi Van Haver, Francis Impens, Sven Eyckerman, Irma Lemmens, Jan Tavernier, et al.
- Single-domain antibodies make a difference(2021)
Authors: Xavier Saelens, Bert Schepens
Pages: 681 - 682 - A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody(2021)
Authors: Iebe Rossey, Ching-Lin Hsieh, Koen Sedeyn, Marlies Ballegeer, Bert Schepens, Jason S. McLellan, Xavier Saelens, Rebecca Ellis Dutch
- In vivo therapy with M2e-specific IgG selects for an influenza A virus mutant with delayed matrix protein 2 expression(2021)
Authors: Silvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, Lei Deng, Emma Job, Kenny Roose, Bert Schepens, Lien Van Hoecke, Philippe Lemey, Xavier Saelens, et al.
- Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies(2020)
Authors: Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Kenny Roose, Loes van Schie, Markus Hoffmann, Stefan Poehlmann, et al.
Pages: 1004 - 1015 - STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters(2020)
Authors: Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Rong Li, Valentijn Vergote, Laura Seldeslachts, Johan Van Weyenbergh, Carolien De Keyzer, Lindsey Bervoets, Sapna Sharma, et al.
- Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies (vol 181, pg 1004, 2020)(2020)
Authors: Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Kenny Roose, Loes van Schie, Markus Hoffmann, Stefan Pohlmann, et al.
Pages: 1436 - 1441 - mRNA encoding a bispecific single domain antibody construct protects against influenza A virus infection in mice(2020)
Authors: Lien Van Hoecke, Rein Verbeke, Dorien De Vlieger, Heleen Dewitte, Kenny Roose, Sharon Van Nevel, Olga Krysko, Claus Bachert, Bert Schepens, Sabine Lentacker, et al.
Pages: 777 - 787 - Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein(2020)
Authors: Heather L. Torrey, Valarmathy Kaliaperumal, Yogesh Bramhecha, Genevieve M. Weir, Ann R. Falsey, Edward E. Walsh, Joanne M. Langley, Bert Schepens, Xavier Saelens, Marianne M. Stanford
Pages: 2007 - 2017